0001209191-22-056613.txt : 20221114
0001209191-22-056613.hdr.sgml : 20221114
20221114162248
ACCESSION NUMBER: 0001209191-22-056613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221110
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Forman Mark S
CENTRAL INDEX KEY: 0001922353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 221385959
MAIL ADDRESS:
STREET 1: C/O PASSAGE BIO, INC.
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-10
0
0001787297
Passage BIO, Inc.
PASG
0001922353
Forman Mark S
ONE COMMERCE SQUARE
2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA
PA
19103
0
1
0
0
Chief Medical Officer
Restricted Stock Unit
2022-11-10
4
A
0
50000
0.00
A
Common Stock
50000
50000
D
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Edgar Cale, Attorney-in-Fact
2022-11-14